Research

An program developed by NewYork-Presbyterian and Weill Cornell Medicine that combines physician telehealth with home health care administered by paramedics helps reduce hospital readmissions for patients with heart failure and other chronic conditions, according to new research.

Weill Cornell Medicine researchers found that restricting telehealth prescriptions for opioid use disorder could prevent thousands from accessing buprenorphine, a medication that helps people recover from addiction.

Dr. Jim Hu was awarded a grant from the Prevent Cancer Foundation to support and innovate initiatives aimed at reducing misinformation, improving patient decision making, and addressing disparities in prostate cancer diagnosis and treatment.

A new Weill Cornell Medicine and Oregon Health & Science University co-authored study provides critical insight for the development of a vaccine that can more effectively block the spread of cytomegalovirus, or CMV, across the placenta to babies before they are born.

A person’s “bioenergetic age” — or how youthfully their cells generate energy — might be a key indicator of whether they’re at risk of developing Alzheimer’s disease, new research from Weill Cornell Medicine shows.

Tuberculosis bacteria rely on a family of genes that help them survive the challenging journey from one person’s lungs to another person’s during coughing, sneezing or talking, according to researchers from Weill Cornell Medicine and the Massachusetts Institute of Technology.

Dr. Jacqueline Burré and a team of researchers were recently awarded an R01 grant from the National Institute of Neurological Disorders and Stroke expected to be $3.9 million over five years. 

A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according to a preclinical study led by Weill Cornell Medicine investigators.

People with Crohn’s disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or microbiota, with the bacterium Mediterraneibacter gnavus being a potential biomarker, according to new study by Weill Cornell Medicine researchers.

A new study unveils a precise picture of how an ion channel found in most mammalian cells regulates its own function with a “ball-and-chain” channel-plugging mechanism. The findings could lead to new drugs that target these channels to treat disorders such as epilepsy and hypertension.

Dr. Heidi Bender, professor of...

A new AI-based system for analyzing images taken over time can accurately detect changes and predict outcomes, according to a study led by investigators at Weill Cornell Medicine, Cornell’s Ithaca campus and Cornell Tech.

Working toward more effective tuberculosis (TB) vaccines, researchers have developed two strains of mycobacteria with "kill switches" that can be triggered to stop the bacteria after they activate an immune response.

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators. 

In their effort to answer a decades-old biological question about how the hepatitis B virus is able to establish infection of liver cells, research led by Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and The Rockefeller University identified a vulnerability that opens the door to new treatments.

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.

Krystyn J. Van Vliet, vice president for research and innovation since 2023, has been named vice president for innovation and external engagement strategy for the university.

Weill Cornell Medicine researchers have found that intracranial hemorrhages, or "brain bleeds," caused by a ruptured blood vessel in the brain doubles a person’s risk of developing dementia later in life.

The relationship between a patient and their provider can significantly influence the quality of care outcomes, particularly when considering provider race concordance, according to a new study led by a Weill Cornell Medical College student.

Two Weill Cornell Medicine physician-scientists, Dr. Niroshana Anandasabapathy and Dr. Rohit Chandwani, have been elected members of the American Society for Clinical Investigation (ASCI) for 2025.